Immobilization of aprotinin to fibrinogen as a novel method for controlling degradation of fibrin gels

Bioconjugate Chemistry

Volumn 18, Issue 3, 2007, Pages 695-701

  Smith, Jason D ^a   Chen, Andrew ^a   Ernst, Lauren A ^a   Waggoner, Alan S ^a   Campbell, Phil G ^a  

^a CARNEGIE MELLON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASSAYS; CAMS; CELL CULTURE; ENZYME INHIBITION; GELS;

APROTININ; CHICK CHORIOALLANTOIC MEMBRANE; CHORIOALLANTOIC MEMBRANE ASSAYS; FIBRIN GELS; FIBROBLAST GROWTH FACTOR-2; IMMOBILISATION; NOVEL METHODS; PROTEASE INHIBITOR; SMALL PROTEINS; SYNTHESIS STRATEGY;

BLOOD VESSELS;

APROTININ; FIBRIN; FIBRINOGEN; FIBROBLAST GROWTH FACTOR 2; FLUORESCENT DYE; PROTEINASE INHIBITOR;

ARTICLE; CHICK; CHORIOALLANTOIS; CONJUGATION; FIBRINOLYSIS; IN VITRO STUDY; NONHUMAN; PROTEIN IMMOBILIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS;

EID: 34347337723     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc060265o     Document Type: Article

References (29)

1. Clark, R. A. (2001) Fibrin and wound healing. Ann. N. Y. Acad. Sci. 936, 355-67.
2. Bunce, L. A., Sporn, L. A., and Francis, C. W. (1992) Endothelial cell spreading on fibrin requires fibrinopeptide B cleavage and amino acid residues 15-42 of the beta chain. J. Clin. Invest. 89, 842-50.
3. Sporn, L. A., Bunce, L. A., and Francis, C. W. (1995) Cell proliferation on fibrin: modulation by fibrinopeptide cleavage. Blood 86, 1802-10.
4. Sahni, A., Odrljin, T., and Francis, C. W. (1998) Binding of basic fibroblast growth factor to fibrinogen and fibrin. J. Biol. Chem. 273, 7554-9.
5. Sahni, A., Sporn, L. A., and Francis, C. W. (1999) Potentiation of endothelial cell proliferation by fibrin(ogen)-bound fibroblast growth factor-2. J. Biol. Chem. 274, 14936-41.
6. Meh, D. A., Mosesson, M. W., DiOrio, J. P., Siebenlist, K. R., Hernandez, I., Amrani, D. L., and Stojanovich, L. (2001) Disintegration and reorganization of fibrin networks during tissue-type plasminogen activator-induced clot lysis. Blood Coagulation Fibrinolysis 12, 627-37.
7. Sierra, D. H. (1993) Fibrin sealant adhesive systems: a review of their chemistry, material properties and clinical applications. J. Biomater. Appl. 7, 309-52.
8. Walker, J. B., and Nesheim, M. E. (1999) The molecular weights, mass distribution, chain composition, and structure of soluble fibrin degradation products released from a fibrin clot perfused with plasmin. J. Biol. Chem. 274, 5201-12.
9. Borges, J., Mueller, M. C., Padron, N. T., Tegtmeier, F., Lang, E. M., and Stark, G. B. (2003) Engineered adipose tissue supplied by functional microvessels. Tissue Eng. 9, 1263-70.
10. Borges, J., Tegtmeier, F. T., Padron, N. T., Mueller, M. C., Lang, E. M., and Stark, G. B. (2003) Chorioallantoic membrane angiogenesis model for tissue engineering: a new twist on a classic model. Tissue Eng. 9, 441-50.
11. Brey, E. M., King, T. W., Johnston, C., McIntire, L. V., Reece, G. P., and Patrick, C. W., Jr. (2002) A technique for quantitative three-dimensional analysis of microvascular structure. Microvasc. Res. 63, 279-94.
12. Clark, R. A. (2003) Fibrin glue for wound repair: facts and fancy. Thromb. Haemostasis 90, 1003-6.
13. Cummings, C. L., Gawlitta, D., Nerem, R. M., and Stegemann, J. P. (2004) Properties of engineered vascular constructs made from collagen, fibrin, and collagen-fibrin mixtures. Biomaterials 25, 3699-706.
14. Hokugo, A., Kubo, Y., Takahashi, Y., Fukuda, A., Horiuchi, K., Mushimoto, K., Morita, S., and Tabata, Y. (2004) Prefabrication of vascularized bone graft using guided bone regeneration. Tissue Eng. 10, 978-86.
15. Sakiyama-Elbert, S. E., and Hubbell, J. A. (2000) Development of fibrin derivatives for controlled release of heparin-binding growth factors. J. Controlled Release 65, 389-402.
16. Urech, L., Bittermann, A. G., Hubbell, J. A., and Hall, H. (2005) Mechanical properties, proteolytic degradability and biological modifications affect angiogenic process extension into native and modified fibrin matrices in vitro. Biomaterials 26, 1369-79.
17. Wong, C., Inman, E., Spaethe, R., and Helgerson, S. (2003) Fibrin-based biomaterials to deliver human growth factors. Thromb. Haemostasis 89, 573-82.
18. Francis, C. W., and Marder, V. J. (1986) Concepts of clot lysis. Annu. Rev. Med. 37, 187-204.
19. Turner, R. B., Liu, L., Sazonova, I. Y., and Reed, G. L. (2002) Structural elements that govern the substrate specificity of the clot-dissolving enzyme plasmin. J. Biol. Chem. 277, 33068-74.
20. Fritz, H., and Wunderer, G. (1983) Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs. Arzneimittelforschung 33, 479-94.
21. Le Guehennec, L., Layrolle, P., and Daculsi, G. (2004) A review of bioceramics and fibrin sealant. Eur. Cell Mater. 8, 1-11; discussion 1-11.
22. Marx, G., and Mou, X. (2002) Characterizing fibrin glue performance as modulated by heparin, aprotinin, and factor XIII. J. Lab. Clin. Med. 140, 152-60.
23. Wolberg, A. S., Gabriel, D. A., and Hoffman, M. (2002) Analyzing fibrin clot structure using a microplate reader. Blood Coagulation Fibrinolysis 13, 533-9.
24. Byrne, D. J., Hardy, J., Wood, R. A., Mcintosh, R., and Cuschieri, A. (1991) Effect of fibrin glues on the mechanical properties of healing wounds. Br. J. Surg. 78, 841-3.
25. Carr, M. E., and Gabriel, D. A. (1980) The effect of dextran 70 on the structure of plasma-derived fibrin gels. J. Lab. Clin. Med. 96, 985-93.
26. Shah, G. A., Nair, C. H., and Dhall, D. P. (1987) Comparison of fibrin networks in plasma and fibrinogen solution. Thromb. Res. 45, 257-64.
27. Weiss, L. E., Amon, C. H., Finger, S., Miller, E. D., Romero, D., Verdinelli, I., Walker, L. M., and Campbell, P. G. (2005) Bayesian computer-aided experimental design of heterogenous scaffolds for tissue engineering. Comput.-Aided Des. 37, 1127-1139.
28. Richardson, T. P., Peters, M. C., Ennett, A. B., and Mooney, D. J. (2001) Polymeric system for dual growth factor delivery. Nat. Biotechnol. 19, 1029-34.
29. Krishnan, L. K., Vijayan Lal, A., Uma Shankar, P. R., and Mohanty, M. (2003) Fibrinolysis inhibitors adversely affect remodeling of tissues sealed with fibrin glue. Biomaterials 24, 321-7.